Looks like Roche is losing its market advantage with its drug like Herceptin, Rituxan and Avastin. Their pricing is being undercut by biosimilar as its drugs patent protection runs out. Now, they are facing fall in market share and reduced profit margin to competition. If they want to maintain its advantage, Roche will have to look to something better and with long patent protection.
Oh, look what have we got here? A UNIQUE Goose with more than 10 years patent protection on the window. And I will tell you this. Based on its past action, Roche is no Scrooge.
https://www.fiercepharma.com/market...etition-by-offering-relevant-discounts-report
Have a good weekend all!
- Forums
- ASX - By Stock
- IMU
- The Momentum will build as the market wakes up
The Momentum will build as the market wakes up, page-22
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $356.9M |
Open | High | Low | Value | Volume |
4.9¢ | 4.9¢ | 4.8¢ | $328.5K | 6.792M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
45 | 5443565 | 4.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.9¢ | 2171910 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
45 | 5443565 | 0.048 |
43 | 4562182 | 0.047 |
49 | 3188200 | 0.046 |
61 | 6392230 | 0.045 |
12 | 2001364 | 0.044 |
Price($) | Vol. | No. |
---|---|---|
0.049 | 2171910 | 5 |
0.050 | 4756889 | 17 |
0.051 | 6179811 | 13 |
0.052 | 2579418 | 10 |
0.053 | 1158504 | 8 |
Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
Featured News
CC9
Chariot Corporation (ASX:CC9) refines Black Mountain strategy, launching Pilot Mine to seize U.S. lithium opportunity
IMU (ASX) Chart |